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Abstract The Ly5.1 mouse, also termed B6.SJL-Ptprca Pepcb/BoyJ, is a congenic strain widely used as a recipient in
animal studies of bone marrow transplant. Our previous study documented that a majority of type I spiral ganglion
neurons (SGNs) in the apical turns of Ly5.1 mice are unmyelinated and aggregate into neuronal clusters, similar to
the spiral ganglion in the human ear. Ouabain, a well known Na-K ATPase inhibitor, has been shown to induce
neuronal degeneration in a variety of neural tissues including the adult gerbil and CBA/CaJ mouse spiral ganglion.
Here, functional and pathological changes of the auditory nerves in young-adult Ly5.1 mice were examined at 3, 7
and 14 days after ouabain exposure. Similar to observations in CBA/CaJ mice, ouabain application selectively
removed type I SGNs, resulting in an immense decline of the auditory nerve function. Hyperplasia of glial cells
was seen in the injured auditory nerves at 7 days after ouabain exposure. Our data indicate that the
“human-like”features of unmyelinated type I SGNs have no protective impact on the fate of SGNs after ouabain
exposure. Cells incorporating bromodeoxyuridine (BrdU) and expressing Sox2 were also counted in the auditory
nerves of control and ouabain-treated ears. The number of Sox2+ glial cells significantly increased at 3 and 7 days
post-treatment. Interestingly, the highest density of BrdU+ cells appeared in the apical turn of the injured auditory
nerve shortly after ouabain exposure, suggesting that the pattern of SGN loss at the apical turn in Ly5.1 mouse may
have some impact on the reaction of non-neuronal cells in response to acute ototoxic drug exposure in the auditory
nerve.
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Introduction
Spiral ganglion neurons (SGNs) and their processes
(afferent auditory nerves) are the primary carriers that
delivery auditory information from the sensory hair
cells of the inner ear to the central nervous system.
There are two subclasses of SGNs and afferent auditory
nerve fibers: type I and type II. 1,2 Type I afferent nerve
fibers synapse inner hair cells and are all myelinated.
In contrast, type II nerve fibers are unmyelinated and
innervate the outer hair cells. In most mammalian spe⁃
cies, type I SGN cell body is also heavily myelinated,
which represents about 90-95% of SGNs. The
remaining type II neurons are unmyelinated and located
primarily in the periphery of the spiral ganglion. How⁃
ever, in the human inner ear, type I SGNs are mostly
unmyelinated .3,4,5,6 The functional basis of this ana⁃
tomical difference in spiral ganglion between human
and other mammalian species is still unclear.
The Ly5.1 mouse, also termed B6.SJL-Ptprca Pepcb/
BoyJ, is a congenic strain widely used as a recipient in
animal studies of bone marrow transplant .7,8 The
Ly5 gene includes allelic forms Ly5.1 and Ly5.2.
This difference allows the identification and differentia⁃
tion of the donor Ly5.2 cells from recipient Ly5.1cells
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using immunofluorescent staining and flow cytometry.
In a previous study, we found that a majority of type I
SGNs in the apical turns of Ly5.1 mice were unmyelin⁃
ated and mostly aggregated into neuronal clusters,
which have a high level of similarity to human spiral
ganglion (8). This mouse strain provides a unique ani⁃
mal model for studying human auditory nerve function
as well as pathological changes of the human spiral gan⁃
glion with aging, neurodegenerative diseases and expo⁃
sure to ototoxic drugs.
Ouabain was originally isolated from the ripe seeds
of the African plant strophanthus gratus and the bark of
Acokanthera ouabaio. It is a well-known Na,
K-ATPase blocker and was widely used in vitro studies
to specifically inhibit the sodium pumps in a variety of
cell types including neurons .9 Application of ouabain
to the round window of young-adult gerbils 10,27 and
CBA/CaJ mice 11 induced a selective loss of type I
SGNs by apoptotic- like degeneration. In addition, we
also found an upregulation of Sox2 transcription factor
and increased glial cell proliferation in the spiral gan⁃
glion of young-adult CBA/CaJ mice shortly after oua⁃
bain exposure. 11 In this study, we examined if 1) the
‘human-like features’of the spiral ganglion in Ly5.1
mice protect SGN from degeneration secondary to oua⁃
bain ototoxicity; and 2) glial cell proliferation and Sox2
upregulation occur differently in Ly5.1 mice as com⁃




B6.SJL-Ptprca Pepcb/BoyJ (Ly5.1) mice were bred
in-house with original breeding pairs purchased from
The Jackson Laboratory (Bar Harbor, ME, see database
for Ly5.1 mice at http://jaxmice.jax.org/strain/002014.
html, Stock# 002014) and raised in a low-noise envi⁃
ronment at the Animal Research Facility of the Medical
University of South Carolina. CBA/CaJ and C57BL/6J
mice purchased from The Jackson Laboratory were
used as the controls in the morphological observations.
All mice received food and water ad libitum and were
maintained on a 12-hour light/dark cycle. Mice of both
genders aged 1 to 3 months (weighing 16-25g ) were
used in the study. Throughout the paper, the term
“young adult mice”applies to all of the 4 to 12
week-old mice. All aspects of the animal research
were conducted in accordance with the guidelines of
the Institutional Animal Care and Use Committee of the
Medical University of South Carolina. Prior to data
acquisition, mice were examined for signs of external
ear canal and middle ear obstruction. Mice with any
symptoms of ear infection were excluded from the
study.
Ly5.1 mice were administered daily intra-peritoneal
doses of bromodeoxyuridine (BrdU, 100 mg/kg, Sigma)
for five days including the day preceding ouabain treat⁃
ment, the day of ouabain treatment, and the three days
following ouabain treatment. BrdU incorporation analy⁃
sis was processed at 3,7 and 14 days after ouabain treat⁃
ment.
Physiological procedures
Mice were anesthetized by an intraperitoneal injec⁃
tion of xylazine (20mg/kg) and ketamine (100mg/kg)
and placed in a head holder in a sound-isolation room.
Young adult Ly5.1 mice were used for physiological
measurements before and after ouabain treatment.
Auditory brainstem responses (ABRs) were recorded
via customized needle electrodes inserted at the vertex
(+ ) and test-side mastoid (-), with a ground in the
control-side leg. The acoustic stimuli were generated
using Tucker Davis Technologies equipment III (Tuck⁃
er-Davis Technologies, Gainesville, FL, USA) and a
SigGen software package. The calibration was completed
using a Knowles microphone in a probe tube clipped to
the pinna. The signals were delivered into the mouse
ear canal through a 10 mm long (3-5 mm diameter)
plastic tube. ABR thresholds, defined as the lowest
sound levels at which the response peaks are clearly
present as read by the eye from stacked wave forms,
were obtained. ABRs were evoked at half octave fre⁃
quencies from 4 to 45 kHz with 5 ms duration tone pips
with cos2 rise/fall times of 0.5 ms delivered at 31/s.
Sound levels were reduced in 5-dB steps from 90 dB SPL
to 10 dB SPL below thresholds. At each sound level,
300-500 responses were averaged, using an“artifact
reject”whereby response waves were discarded when
peak to peak amplitude exceeded 50 mV. Physiological
results were analyzed for individual frequencies, and
then averaged for each of these frequencies from 4.0 to
40 kHz.
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Surgical procedures
Surgical approach employed to expose the round win⁃
dow of the Ly5.1 mouse was modified slightly from a
previous description (11,12). The cochlea was exposed
through a post-auricular approach and a small perfora⁃
tion was created to expose the round window niche.
About 5 μl ouabain solution (1 mM in normal saline)
was applied to the round window, filling the niche com⁃
pletely, using a 26 gauge needle and tuberculin syringe
under direct microscopic guidance. The total time of
ouabain exposure was 45-60 minutes, during which
ouabain was applied every 10 minutes. The right ear
was the operative ear while the left ear served as a con⁃
trol. The mice were allowed to recover for 3, 7 and 14
days after ouabain exposure. Note that ouabain treated
mice showing no ABR threshold shift or a threshold
shift less than 20 dB SPL were excluded from further
study.
Morphological and immunohistochemical analysis
Young adult mice were used for the following proce⁃
dures including morphological and immunohistochemi⁃
cal analysis. For morphological observation, the anes⁃
thetized animals were perfused via cardiac catheter
first with 10 ml of normal saline containing 0.1 % sodi⁃
um nitrite and then 15 ml of a mixture of 4% parafor⁃
maldehyde and 2% glutaraldehyde in 0.1M phosphate
buffer, pH 7.4. After removing the stapes and open⁃
ing the oval and round windows, 0.5 ml of fixative
was perfused gently into the scala vestibuli through the
oval window. The inner ears were dissected free and
immersed in fixative overnight at 4 °C. Decalcification
was completed by immersion in about 50 ml of 120 mM
solution of ethylenediamine tetracetic acid (EDTA), pH
7.2, with gentle stirring at room temperature for 2-3
days with daily changes of the EDTA solution. The tis⁃
sues were postfixed with a 1% osmium tetroxide for 1
hour, dehydrated and embedded in Epon LX 112 resin.
Semi-thin sections approximately 1 mm thick were cut
and stained with toluidine blue.
For immunohistochemistry, the inner ears were pre⁃
pared following the procedure described above but sub⁃
stituting 4 % paraformaldehyde as fixative, decalcified
with EDTA, cryprotected in 30 % sucrose in PBS and
embedded in Tissue-Tek OCT compound (Electron Mi⁃
croscopy Science, FT. Washington, PA). For BrdU
staining, additional pre-treatment for frozen tissue
sections was included as follows: the sections were
denatured with 2N HCl in 0.05% Tween-20 in PBS,
pH7.4 for 30 min at 37 °C, and neutralized in 0.1 M
sodium borate pH 8.5 for 10 min.
Frozen sections or surface preparations of cochlear
tissue were incubated overnight at 4 °C with a primary
antibody diluted in PBS. The primary antibodies used
in this study were mouse anti-BrdU (1:1000, B2531,
Sigma, Atlanta, GA), mouse anti-neurofilament 200 (1:
200, Clone N52, N0142; Sigma, Atlanta, GA), mouse
anti-connexin 43 (1:200, Clone N52, 13-8300; Zymed
Labs, Carlsbad, CA), goat anti-Sox2 (1:200, sc17320,
Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit
anti-Sox2 (1:500, AB5603, Chemicon, Temecula, CA).
For double staining protocols, the primary antibodies
selected were generated in different species (e.g., one
mouse monoclonal antibody with one rabbit or goat
polyclonal antibody). Note that the antibodies gener⁃
ated in either host gave the same immunolabeling
patterns. Biotinylated secondary antibody binding
was detected with FITC-conjugated avidin D (1:
150) (Vector, Burlingame, CA). Detection of the sec⁃
ondary antigens utilized Texas-red conjugated avidin D
(1:150) (Vector, Burlingame, CA) for visualization. Nu⁃
clei were counterstained with propidium iodide (PI) in
specimens stained with only one primary antibody.
Staining of control sections for all primary antibodies in⁃
cluded omission of the primary antibody or substitution
with similar dilutions of non-immune serum of the ap⁃
propriate species. No regionally specific staining was
detected in any of these control experiments.
The mouse monoclonal anti-BrdU was produced by
clone BU33 and raised against BrdU incorporated into
DNA or coupled to a protein carrier. It recognized
proliferative cells in the nuclei of frozen and paraf⁃
fin-embedded tissue sections of animals treated with
an in vivo administration of BrdU (manufacturer’s
technical information). In this study, we verified that
the antibody does not reveal staining in ouabain-treat⁃
ed auditory nerves without BrdU administration.
The goat polyclonal antibody to Sox2 was raised
against a peptide corresponding to C-terminus aa
227-293 of human origin (manufacturer’s technical
information). Using this antibody, previous studies
have shown that Sox2 is expressed in the nuclei of the
multipotent progenitor cells in mouse eye 13 and in the
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specific neural progenitor cells in the postnatal hippo⁃
campal subventricular zone. 14 The rabbit polyclonal an⁃
tibody to Sox2 was generated against a synthetic pep⁃
tide from human Sox2 (Acc# P448431, manufacturer’s
technical information). Both antibodies reveal simi⁃
lar staining patterns in the mouse inner ear. Previ⁃
ous immunocytochemistry studies demonstrated that
Sox2 is highly expressed in all prosensory and sensory
epithelia of the developing mouse inner ear, 15 the nu⁃
clei of the supporting cells in both auditory and vestibu⁃
lar organs of the adult mouse ear, 16 and in the nuclei of
Schwann cells in the developing chicken cochleovestib⁃
ular ganglion .17
The mouse monoclonal antibody to neurofilament
200 (phosphorylated and non-phosphorylated, clone
N52) reacts with the neurofilament of molecular weight
200 kDa in rat spinal cord extracts (manufacturer’s
technical information). When tested by immunoblotting
on pig neurofilament polypeptides, the antibody reacts
with an epitope in the tail domain of neurofilament 200,
also referred to as the H-subunit, which is present on
both the phosphorylated and non-phosphorylated forms
of this polypeptide. The staining patterns with neurofil⁃
ament 200 in the mouse auditory nerve here were simi⁃
lar to those in previous reports. 18-22
The mouse monoclonal anti-connexin 43 was gener⁃
ated against a synthetic peptide that corresponds to a
cytoplasmic sequence located near the C-terminus of rat
connexin 43 and is specific for the unphosphorylated
form of connexin 43. 22 The activity of this antibody has
been confirmed by Western blotting in protein extracts
from mouse and rat brain, mouse, dog and human heart
and C1-9 rat liver cells (manufacturer’s technical infor⁃
mation). Previous studies using this antibody indicated
that connexin 43 is expressed preferentially by glial
cells in the central nervous system and by satellite cells
in the trigeminal ganglion. 23
Quantitative analysis of BrdU- and Sox2-expressing
cells was performed using cochleas from three to five
young adult mice of each group. Cell count data were
collected from five to six 15μm mid-modiolar frozen
sections per cochlea. The values of the sampling area
and numbers of BrdU- and Sox2-expressing cells were
determined and collected using the Automatic Measure⁃
ment Feature of AxioVison 4.8 software (Carl Zeiss
Inc., Jena, Germany). The sections used for counting
were at least 30 μm apart (e.g., cell counting was per⁃
formed on 1 in every 3 serial sections). Confirmation of
double-labeling Sox2 with BrdU was performed by
focusing through the full height of the section.
The sections were examined either with a Zeiss Axio
Observer or a Zeiss LSM5 Pascal confocal microscope
(Carl Zeiss Inc., Jena, Germany). The captured images
were processed using Image Pro Plus software (Media
Cybernetics, MD), AxioVison 4.8 (Carl Zeiss Inc., Jena,
Germany) and Zeiss LSM Image Browser Version 2,0,
70 (Carl Zeiss Inc., Jena, Germany). Adobe Photoshop
CS2 was employed to adjust brightness, contrast, and
sharpness of images with identical setting for all panels.
Alterations were not performed on images used for
quantitative purposes.
Data analysis
Unless otherwise specified, all data in the figures are
presented as mean ± standard error of the mean
(SEM). Data for the ABR thresholds, the density of
Sox2+, BrdU+ and Sox2+/BrdU+ were analyzed by ANOVA
or two tailed, unpaired t test (SPSS, Chicago, IL). A
value of p <0.05 was considered to be statistically
significant. Control samples were the untreated ear
from the same animal unless otherwise indicated.
Results
Expression patterns of NF 200 and connexin 43 in
normal auditory nerve
Neurofilament 200 (NF200) antibody stained interme⁃
diate filaments of neuronal cells, which provide support
for normal axonal radial growth. NF 200 is a widely
used neural marker for both type I and type II SGNs
(18,19,20,24). As shown in Figure 1, all SGNs in CBA/
CaJ, C57BL/6J and Ly5.1 mice were stained positively
for NF200. A large number of SGNs in the apical and
middle turns of normal young-adult Ly5.1 mice lacked
myelin sheaths around their cell bodies resulting in a
unique staining pattern with clustering NF200+ neurons
(Fig. 1C). In contrast, NF200 + SGNs in CBA/CaJ and
C57BL/6J mouse ears were ensheathed with connexin
43+ myelinated sheaths, forming a honey-comb-like
staining pattern (Figs. 1A,B).
Connexin 43 is expressed by glial cells in both the
central and peripheral nervous system. 23Our data are
the first to demonstrate that connexin 43 is expressed
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by myelin sheaths and Schwann cells in the mouse audi⁃
tory nerve including CBA/CaJ, C57BL/6J and Ly5.1
strains (Fig. 1). A lack of connexin 43 expression with⁃
in neural aggregates further validated the deficiency of
Schwann cell processes in the Ly5.1mouse spiral gangli⁃
on. Connexin 43 expression remained positive in almost
all nerve processes within the osseous spiral lamina in
the Ly5.1 mouse ear (Fig. 1D).
Decline of auditory nerve function and type I SGN
degeneration after ouabain exposure
Ouabain applied to the round window of young adult
Ly5.1 mice induced a severe decline of auditory nerve
function within a few days (Fig. 2). Auditory brainstem re⁃
sponse (ABR) wave I thresholds were markedly elevated
across all frequencies at 3, 7 and 14 days post-expo⁃
sure. There is no statistical difference in ABR wave I
thresholds across all frequencies among the three
post-exposure groups (unpaired t-test, p>0.05), indicat⁃
ing permanent threshold shifts in ABR wave I occurred
as early as 3 days post-exposure.
Figure 3 illustrated pathological changes of the spiral
ganglia within Rosenthal’s canal in the apical, middle
and basal turns. In the contralateral control ears, the
unmyelinated type I neuron clusters were seen mostly
in the apical and also occasionally in the middle turns
of Ly5.1 mice (Fig. 3A,B), similar to our previous obser⁃
vations in this mouse strain 8. By 7 days after ouabain
exposure, all these neuronal clusters disappeared. A
small number of surviving SGNs were often seen in the
periphery of the spiral ganglion across all three turns.
Figure 1 Immunostaining for connexin 43 and NF200. Confocal images of cochleas from adult CBA/CaJ, C57BL/6J and Ly5.1 mice.
Sections from apical turns dual labeled for TuJ1 III β-tubulin (red, upper panel) and connexin 43 (green, middle panel). A,B: connexin
43+ Schwann cells and their processes ensheathing NF200+ SGNs in a CBA/CaJ mouse and a C57BL/6J mouse. C: Staining for connexin
43 is lacking around the NF200 + neurons within three larger neural clusters (*) in a Ly5.1 mouse. D: TuJ1-positive myelinated
nerve fibers (red) are surrounded by connexin 43-positive Schwann cell processes in the osseous spiral lamina of a Ly5.1 mouse. Scale
bar: 10 μm in D (applies to A-C).
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In addition, most myelinated auditory fibers disap⁃
peared in the osseous spiral lamina (Figs. 4A,C) and
modiolus where the glial transition zone is located
(Figs. 4C,D). Hyperplasia of glial cells was also seen in
the injured auditory nerve within these two areas, indi⁃
cating the activation of glial cells occurs both in
Schwann cells and oligodendrocytes. A large num⁃
ber of spindle-shaped glial cells were seen within
most areas of Rosenthal’s canal in the apical turn and
lateral portions of Rosenthal’s canal in the middle and
basal turns (Figs. 3D-F).
Figure 3 SGN degeneration and glial cell hyperplasia in Rosenthal’s canal of the ouabain-treated Ly5.1 mouse ear. Semi-thin radial
sections were stained with toluidine blue. A, B, C: SGNs in Rosenthal’s canal of the apical, middle and basal turns in the normal control
ear of a young adult Ly5.1 mouse. SGNs can be easily distinguished from glial cells by their round and lighter nucleus. Unmyelinated
and aggregated neuronal clusters (*) were seen in the apical turn (A) and the middle turn (B), but not in the basal turn (C). D, E, F: A
marked loss of SGNs was seen in all three turns of the contra-lateral treated ear of the Ly5.1 mouse at 7 days after ouabain exposure.
Black arrows indicate a few surviving SGNs. Numerous spindle-shape glial cells were present within Rosenthal’s canal, in particular in
the apical turn (D) and the lateral portion of Rosenthal’s canal in the middle and basal turns (E, F). Scale bar =12 μm in F (applies to
A-F)
Figure 2 Auditory nerve function decline in ouabain-treated
young-adult Ly5.1 mice. ABRs to pure tones were recorded at 3
(n=7), 7 (n=8) and 14 (n=6) days after ouabain exposure. The da⁃
ta were plotted as mean ABR thresholds before and after treat⁃
ment. Three days after ouabain treatment ABR thresholds were
markedly increased at all tested frequencies; ABR thresholds con⁃
tinued to increase at 7 days and 14 days after treatment.
Figure 4 Demyelination and glial cell hyperplasia in the osseous
spiral lamina and modiolus of the ouabain-treated Ly5.1 mouse
ear. Semi-thin radial sections were stained with toluidine blue.
A, B: Seven days after ouabain treatment, most myelinated
sheaths within the osseous spiral lamina (osl) disappeared in the
apical and basal turn of a treated Ly5.1 mouse ear. Numerous
spindle-shaped glial cells were seen within the osseous spiral
lamina of the treated ear. C, D: Demyelination and hyperplasia of
glial cells within the modiolus (MO) of another mouse at 7 days
post-treatment. Scale bar = 7 μm in D (applies to A-D).
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Increased Sox2+ and BrdU+/Sox2+ glial cells in audi⁃
tory nerve after ouabain exposure
To further identify the cellular and molecular charac⁃
teristics of these activated glial cells, dual-immunos⁃
taining for Sox2 and BrdU was performed in the Ly5.1
mouse ears at 3, 7 and 14 days after ouabain exposure
(Figs. 5-7). The transcription factor Sox2 + is predomi⁃
nantly expressed in undifferentiated neural cells during
development and adult neurogenesis after injury. 25,26 In
the contralateral normal ear, a few of Sox2 + cells were
seen in Rosenthal’s canal across all turns (Figs. 5A,C).
In contrast, little or no staining of Sox2+ cells was pres⁃
ent in the osseous spiral lamina of normal control ears
(data not shown).
Following ouabain treatment, the number of Sox2 +
cells within Rosenthal’s canal significantly increased
at 3 and 7 days post-treatment in all three turns (Fig.
7A) (ANOVA, p<0.05). The mean density (cells/mm2)
of Sox2+ cells in the apical, middle and basal turns was
851, 1226 and 1454 for controls, 8288, 7670 and 7111
for the 3 days post-treatment ears, and 7777, 6981 and
5531 for the 7 days post-treatment ears, respectively.
By 14 days after ouabain exposure, a significant
increase in Sox2+ cells was seen in the apical and mid⁃
dle turns (unpaired t-test, p<0.05), but not in basal
turn (unpaired t-test, p>0.05).
The use of BrdU incorporation assays revealed that
very few cells were mitotic in the normal auditory nerve
(Figs. 5A,C). These results agree with our previous
observations in normal adult gerbil and CBA/CaJ mice.
11,27 The proliferative cells in the normal Ly5.1 mouse
ears are most likely non-neuronal cells such as glial
cells, fibroblasts, vascular endothelial cells or microgli⁃
al cells based on the morphological characteristics of
their nuclei. Following ouabain exposure, the number
of BrdU + cells was significantly increased 3, 7 and 14
days after ouabain treatment (ANOVA, p<0.05) (Fig.
7B). In particular, the highest density in BrdU + cells
appeared in the apical turn at 3 days after ouabain treat⁃
ment (ANOVA, p<0.05). The mean density (cells/mm2)
of BrdU + cells within Rosenthal’s canal in the apical,
middle and basal turns was 37, 17 and 5 for the control
ears, and 1103, 369 and 305 for the 3 days post-treat⁃
ment ears, respectively.
To determine the extent of proliferation in Sox2 +
cells, dual-staining for BrdU with Sox2 was quantita⁃
tively analyzed in the control and ouabain-treated ears
(Figs. 7 C,D). A significant increase in BrdU +/Sox2 +
cells within Rosenthal’s canal was seen in all three
turns at 3 days post-treatment and in the apical and
middle turns at 7 and 14 days post-treatment (unpaired
t-test, p<0.05). By 3 days after ouabain exposure,
51% (573/1103), 48% (178/369) and 89% (273/305)
of BrdU + cells were co-labeled with Sox2 in the apical,
middle and basal turns of those ouabain-treated auditory
nerves, respectively. To determine overall proliferative
ability of Sox2 + glial cells in injured auditory nerves,
percentages of BrdU + cells in Sox2 + cell populations
were also analyzed as shown in Fig. 7D. About 2-7%
of Sox2 + cells stained positive with BrdU at 3 days
post-treatment, suggesting that a small portion of Sox2+
glial cells in the auditory nerve of young-adult Ly5.1
mouse inner ear are capable of self-renewal.
Figure 5 Increased Sox2+ and BrdU+ cells within Rosenthal’s
canal of the ouabain-treated Ly5.1 mouse ear. A: Dual-immu⁃
nostaining for Sox2 (green) and BrdU (red, arrows) in a normal
Ly5.1 mouse ear showing only one BrdU + cell that was co-la⁃
beled with Sox2 (white arrowhead) in the apical Rosenthal’s ca⁃
nal. A few Sox2+ glial cells (white arrows) were seen in the pe⁃
riphery of the spiral ganglion. B: Increased number of Sox2 +
(green) and Sox2+/BrdU+ (yellow) cells in the apical Rosenthal’
s canal 7 days after ouabain treatment. C: Dual-immunostain⁃
ing for Sox2 (green) and BrdU (red, arrows) in a normal Ly5.1
mouse ear showing no BrdU + cells (red) that were co-labeled
with Sox2 in the basal Rosenthal’s canal. A few Sox2 + glial
cells (green) were evenly distributed within Rosenthal’s canal.
D: Increased number of Sox2+ (green) and Sox2+/BrdU+ (yellow)
cells in the basal Rosenthal’s canal 7 days after ouabain treat⁃
ment. Scale bar =10 μm in D (applies to A-D).
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Figure 6 Proliferative Sox2+ glial cells within the osseous spiral lamina and modiolus of the ouabain-treated Ly5.1 mouse ear. A,
B: Dual-immunostaining for Sox2 (green) and BrdU (red, arrows) in an ouabain-treated Ly5.1 mouse ear showing several BrdU + cells
that were co-labeled with Sox2 (white arrowheads) in the apical and basal Rosenthal’s canal. The auditory nerve section was prepared
from a mouse 7 days after ouabain exposure. C: Numerous Sox2 + (green) and Sox2 +/BrdU + (yellow) cells in the modiolus of the oua⁃
bain-injured auditory nerve. Scale bar =10 μm in C (applies to A-C).
Figure 7 Increased BrdU+ and BrdU+/Sox2+ cells in the auditory nerve of ouabain-treated Ly5.1 mice. A: Mean density of Sox2+ cells
within Rosenthal’s canal in the apical, middle, and basal turns of control, 3, 7 and 14 and 30 day post-treated ears (n=3-5 per group).
B: Mean density of BrdU+ cells within Rosenthal’s canal in the apical, middle, and basal turns of control, 3, 7 and 14 day post-treated
ears (n=3-5 per group). C: Mean density of BrdU+/Sox2+ cells within Rosenthal’s canal. D: Mean density of BrdU+/Sox2+cells among the
total Sox2+ cells.
Dissussion
In our previous study, we have indicated that the spi⁃
ral ganglion of the young-adult Ly5.1 mouse has a high
degree of“human-like features”such as unmyelinated
type I SGNs and aggregated neural clusters in the api⁃
cal and middle turns 8. Within these clusters, type I
SGNs are in direct somato-somatic apposition, with no
intervention with Schwann cells or neural processes.
These unique morphological characteristics in Ly5.1
mouse may have some impact on the fate of SGNs and
other cells of the auditory nerve in response to ouabain
exposure.
Here, we have described the auditory functional de⁃
clines and pathological changes of SGNs and their pro⁃
cesses in the young-adult Ly5.1 mice after ouabain ex⁃
posure. Similar to our previous studies in the young
adult gerbil and CBA/CaJ mice 10,11,27, ouabain can selec⁃
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tively induce the degeneration of type I SGNs in the
young adult Ly5.1 mouse. Permanent ABR threshold
shifts across all tested frequencies were seen as early as
three day after ouabain exposure. A majority of SGNs,
including these neural clusters in the apical and middle
turns, disappeared by 7 days after ouabain exposure.
These results demonstrate that“human-like features”of
unmyelinated type I SGNs have no any protective impact
at all on the fate of SGNs after ouabain exposure,
at least for the administrated protocol we estab⁃
lished .11,27
Our study also demonstrates that 1) Sox2 is expressed
in a subset of glial cells in the auditory nerve of the
adult Ly5.1 mouse glial cells and 2) the adult spiral
ganglion undergoes hyperplasia shortly following oua⁃
bain exposure as previously observed in young-adult
CBA/CaJ mice 27. Interestingly, we found two different
characteristics in the pathological changes of Ly5.1
mouse spiral ganglion after ouabain exposure as com⁃
pared to those in the CBA/CaJ mouse: 1) the highest den⁃
sity of BrdU + cells appeared in the apical turn of
injured auditory nerve 3 days after ouabain exposure;
and 2) the number of Sox2 +/BrdU + cells in the basal
auditory nerve was lower than those in the apical and
middle turns at 7 and 14 days after ouabain exposure.
The high proliferative rate in non-neuronal cells of the
apical turn after ouabain exposure may be associated
with the“human-like”features of unmyelinated type I
SGNs in young-adult Ly5.1 mice. Within neural clus⁃
ters of the Ly 5.1 mouse spiral ganglion, junction-like
symmetrical structures appeared on adjoining plasma
membranes of neighboring neurons .8 These specialized
junction-like structures may be the structural basis of
direct neuron- to-neuron communication, allowing
each neuronal cluster to act as a“functional unit”in
both physiological and pathological conditions including
neuronal degeneration in response to ouabain expo⁃
sure .28 A large number of SGNs dying simultaneously
within a short period may result in a unique injury
microenvironment, which is more favorable for the
de-differentiation and proliferation of glial cells and/or
other non-neuronal cells in the auditory nerve.
Another interesting finding is that the number of
Sox2+/BrdU+ in the basal auditory nerve was lower than
those in the apical and middle turns at 7 and 14 days
after ouabain exposure. A subpopulation of glial cells
up-regulate Sox2 gene and proliferate after injury sug⁃
gest quiescent glial cells are able to revert to more un⁃
differentiated states. 29,30,31 In fact, a certain level of neu⁃
ronal SGN degeneration was seen in the basal turns of
normal young-adult Ly5.1 mice 8 This chronic neuronal
degeneration may be an extrinsic factor that contributes
to the declined ability of glial cell proliferation or dedif⁃
ferentiation in the basal turn of young adult Ly5.1 mice.
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